Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MAILLIARD JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tefferi, A; Li, CY; Reeder, CB; Geyer, SM; Allmer, C; Levitt, R; Michalak, JC; Addo, F; Krook, JE; Witzig, TE; Schaefer, PL; Mailliard, JA
      A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

      LEUKEMIA
    2. Edmonson, JH; Suman, VJ; Dalton, RJ; Bro, WC; Gallenberg, MM; Long, HJ; Levitt, R; Hatfield, AK; Krook, JE; Mailliard, JA; Gerstner, JB
      Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study

      CANCER INVESTIGATION
    3. Buckner, JC; Schomberg, PJ; McGinnis, WL; Cascino, TL; Scheithauer, BW; O'Fallon, JR; Morton, RF; Kuross, SA; Mailliard, JA; Hatfield, AK; Cole, JT; Steen, PD; Bernath, AM
      A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma

      CANCER
    4. Burch, PA; Block, M; Schroeder, G; Kugler, JW; Sargent, DJ; Braich, TA; Mailliard, JA; Michalak, JC; Hatfield, AK; Wright, K; Kuross, SA
      Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracilor 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A north central cancer treatment group study

      CLINICAL CANCER RESEARCH
    5. Bonner, JA; Sloan, JA; Rowland, KM; Klee, GG; Kugler, JW; Mailliard, JA; Wiesenfeld, M; Krook, JE; Maksymiuk, AW; Shaw, EG; Marks, RS; Perez, EA
      Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer

      CLINICAL CANCER RESEARCH
    6. Martenson, JA; Bollinger, JW; Sloan, JA; Novotny, PJ; Urias, RE; Michalak, JC; Shanahan, TG; Mailliard, JA; Levitt, R
      Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial

      JOURNAL OF CLINICAL ONCOLOGY
    7. Loprinzi, CL; Kugler, JW; Sloan, JA; Mailliard, JA; LaVasseur, BI; Barton, DL; Novotny, PJ; Dakhil, SR; Rodger, K; Rummans, TA; Christensen, BJ
      Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

      LANCET
    8. Perez, EA; Hillman, DW; Stella, PJ; Krook, JE; Hartmann, LC; Fitch, TR; Hatfield, AK; Mailliard, JA; Nair, S; Kardinal, CG; Ingle, JN
      A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma

      CANCER
    9. Ingle, JN; Suman, VJ; Johnson, PA; Krook, JE; Mailliard, JA; Wheeler, RH; Loprinzi, CL; Perez, EA; Jordan, VC; Dowsett, M
      Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer

      CLINICAL CANCER RESEARCH
    10. Bonner, JA; Sloan, JA; Shanahan, TG; Brooks, BJ; Marks, RS; Krook, JE; Gerstner, JB; Maksymiuk, A; Levitt, R; Mailliard, JA; Tazelaar, HD; Hillman, S; Jett, JR
      Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    11. Loprinzi, CL; Kugler, JW; Sloan, JA; Mailliard, JA; Krook, JE; Wilwerding, MB; Rowland, KM; Camoriano, JK; Novotny, PJ; Christensen, BJ
      Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

      JOURNAL OF CLINICAL ONCOLOGY
    12. Marschke, RF; Grill, JP; Sloan, JA; Wender, DB; Levitt, R; Mailliard, JA; Gerstner, JB; Ghosh, C; Morton, RF; Jett, JR
      Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    13. Ingle, JN; Suman, VJ; Kardinal, CG; Krook, JE; Mailliard, JA; Veeder, MH; Loprinzi, CL; Dalton, RJ; Hartmann, LC; Conover, CA; Pollak, MN
      A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

      CANCER
    14. GALANIS E; BUCKNER JC; BURCH PA; SCHAEFER PL; DINAPOLI RP; NOVOTNY PJ; SCHEITHAUER BW; ROWLAND KM; VUKOV AM; MAILLIARD JA; MORTON RF
      PHASE-II TRIAL OF NITROGEN-MUSTARD, VINCRISTINE, AND PROCARBAZINE IN PATIENTS WITH RECURRENT GLIOMA - NORTH CENTRAL CANCER-TREATMENT GROUP RESULTS

      Journal of clinical oncology
    15. OCONNELL MJ; NAGORNEY DM; BERNATH AM; SCHROEDER G; FITZGIBBONS RJ; MAILLIARD JA; BURCH P; BOLTON JS; COLONOTERO G; KROOK JE
      SEQUENTIAL INTRAHEPATIC FLUORODEOXYURIDINE AND SYSTEMIC FLUOROURACIL PLUS LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL-CANCER CONFINED TO THE LIVER

      Journal of clinical oncology
    16. TAYLOR CW; GREEN S; DALTON WS; MARTINO S; RECTOR D; INGLE JN; ROBERT NJ; BUDD GT; PARADELO JC; NATALE RB; BEARDEN JD; MAILLIARD JA; OSBORNE CK
      A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY

      Journal of clinical oncology
    17. CREAGAN ET; HESTORRF RD; SUMAN VJ; MAILLIARD JA; NAIR S; KROOK JE; KUGLER JW; MARSCHKE RF; MICHALAK JC; TSCHETTER LK
      COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY

      American journal of clinical oncology
    18. Maksymiuk, AW; Marschke, RF; Tazelaar, HD; Grill, J; Nair, S; Marks, RS; Brooks, BJ; Mailliard, JA; Burton, GM; Jett, JR
      Phase II trial of topotecan for the treatment of mesothelioma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    19. BONNER JA; MCGINNIS WL; STELLA PJ; MARSCHKE RF; SLOAN JA; SHAW EG; MAILLIARD JA; CREAGAN ET; AHUJA RK; JOHNSON PA
      THE POSSIBLE ADVANTAGE OF HYPERFRACTIONATED THORACIC RADIOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG-CARCINOMA - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP PHASE-III STUDY

      Cancer
    20. CHONG SF; BRETSCHER ME; MAILLIARD JA; TSCHETTER LK; KIMMEL DW; HATFIELD AK; LOPRINZI CL
      PILOT-STUDY EVALUATING LOCAL-ANESTHETICS ADMINISTERED SYSTEMICALLY FOR TREATMENT OF PAIN IN PATIENTS WITH ADVANCED CANCER

      Journal of pain and symptom management
    21. PITOT HC; WENDER DB; OCONNELL MJ; SCHROEDER G; GOLDBERG RM; RUBIN J; MAILLIARD JA; KNOST JA; GHOSH C; KIRSCHLING RJ; LEVITT R; WINDSCHITL HE
      PHASE-II TRIAL OF IRINOTECAN IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA

      Journal of clinical oncology
    22. GOLDBERG RM; HATFIELD AK; KAHN M; SARGENT DJ; KNOST JA; OCONNELL MJ; KROOK JE; MAILLIARD JA; WIESENFELD M; SCHAEFER PL; TIRONA MT; MOERTEL CG
      PROSPECTIVELY RANDOMIZED NORTH CENTRAL CANCER-TREATMENT GROUP TRIAL OF INTENSIVE-COURSE FLUOROURACIL COMBINED WITH THE L-ISOMER OF INTRAVENOUS LEUCOVORIN, ORAL LEUCOVORIN, OR INTRAVENOUS LEUCOVORIN FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    23. OCONNELL MJ; MAILLIARD JA; KAHN MJ; MACDONALD JS; HALLER DG; MAYER RJ; WIEAND HS
      CONTROLLED TRIAL OF FLUOROURACIL AND LOW-DOSE LEUCOVORIN GIVEN FOR 6 MONTHS AS POSTOPERATIVE ADJUVANT THERAPY FOR COLON-CANCER

      Journal of clinical oncology
    24. INGLE JN; TWITO DI; SUMAN VJ; KROOK JE; MAILLIARD JA; WINDSCHITL HE; MARSCHKE RF
      EVALUATION OF INTRAVENOUS 6-THIOGUANINE AS FIRST-LINE CHEMOTHERAPY INWOMEN WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    25. INGLE JN; KARDINAL CG; SUMAN VJ; VEEDER MH; SCHAEFER PL; KIRSCHLING RJ; MAILLIARD JA
      MITOXANTRONE DOSE AUGMENTATION UTILIZING FILGRASTIM SUPPORT IN COMBINATION WITH FIXED-DOSE 5-FLUOROURACIL AND LEUCOVORIN IN WOMEN WITH METASTATIC BREAST-CANCER

      Breast cancer research and treatment
    26. HARTMANN LC; TSCHETTIER LK; HABERMANN TM; EBBERT LP; JOHNSON PS; MAILLIARD JA; LEVITT R; SUMAN VJ; WITZIG TE; WIEAND HS; MILLER LL; MOERTEL CG
      GRANULOCYTE-COLONY-STIMULATING FACTOR IN SEVERE CHEMOTHERAPY-INDUCED AFEBRILE NEUTROPENIA

      The New England journal of medicine
    27. INGLE JN; JOHNSON PA; SUMAN VJ; GERSTNER JB; MAILLIARD JA; CAMORIANO JK; GESME DH; LOPRINZI CL; HATFIELD AK; HARTMANN LC
      A RANDOMIZED PHASE-II TRIAL OF 2 DOSAGE LEVELS OF LETROZOLE AS 3RD-LINE HORMONAL-THERAPY FOR WOMEN WITH METASTATIC BREAST-CARCINOMA

      Cancer
    28. HAMMACK JE; MAILLIARD JA; LOPRINZI CL; ROSPOND RM; OFALLON JR; WILWERDING MB; REUTER NF; MICHALAK JC; FIDLER P; MISER AW
      TRANSDERMAL FENTANYL IN THE MANAGEMENT OF CANCER PAIN IN AMBULATORY PATIENTS - AN OPEN-LABEL PILOT-STUDY

      Journal of pain and symptom management
    29. ROWLAND KM; LOPRINZI CL; SHAW EG; MAKSYMIUK AW; KUROSS SA; JUNG SH; KUGLER JW; TSCHETTER LK; GHOSH C; SCHAEFER PL; OWEN D; WASHBURN JH; WEBB TA; MAILLIARD JA; JETT JR
      RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY

      Journal of clinical oncology
    30. MARTENSON JA; HYLAND G; MOERTEL CG; MAILLIARD JA; OFALLON JR; COLLINS RT; MORTON RF; TEWFIK HH; MOORE RL; FRANK AR; URIAS RE; DEMING RL
      OLSALAZINE IS CONTRAINDICATED DURING PELVIC RADIATION-THERAPY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL

      International journal of radiation oncology, biology, physics
    31. SWAROOP VS; AHLQUIST DA; WIEAND HS; MCGILL DB; CHA SS; LOPRINZI CL; OCONNELL MJ; MAILLIARD JA
      STOOL SCREENING COMPLIANCE AMONG COLORECTAL-CANCER RELATIVES - GENDERAND AGE EFFECTS

      Gastroenterology
    32. CASTRO M; VEEDER MH; MAILLIARD JA; TAZELAAR HD; JETT JR
      A PROSPECTIVE-STUDY OF PULMONARY-FUNCTION IN PATIENTS RECEIVING MITOMYCIN

      Chest
    33. RUBIN J; GALLAGHER JG; SCHROEDER G; SCHUTT AJ; DALTON RJ; KUGLER JW; MORTON RF; MAILLIARD JA; BURCH PA
      PHASE-II TRIALS OF 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC GASTRIC OR PANCREATIC-CARCINOMA

      Cancer
    34. DHODAPKAR MV; INGLE JN; CHA SS; MAILLIARD JA; WIEAND HS
      PROGNOSTIC FACTORS IN ELDERLY WOMEN WITH METASTATIC BREAST-CANCER TREATED WITH TAMOXIFEN - AN ANALYSIS OF PATIENTS ENTERED ON 4 PROSPECTIVECLINICAL-TRIALS

      Cancer
    35. HABERMANN TM; HARTMANN LC; TSCHETTER LK; WIEAND HS; EBBERT LP; MAILLIARD JA; LEVITT R; WITZIG TE; SUMAN V
      RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS

      Blood
    36. WILWERDING MB; LOPRINZI CL; MAILLIARD JA; OFALLON JR; MISER AW; VANHAELST C; BARTON DL; FOLEY JF; ATHMANN LM
      A RANDOMIZED, CROSSOVER EVALUATION OF METHYLPHENIDATE IN CANCER-PATIENTS RECEIVING STRONG NARCOTICS

      Supportive care in cancer
    37. WIESENFELD M; OCONNELL MJ; WIEAND HS; GONCHOROFF NJ; DONOHUE JH; FITZGIBBONS RJ; KROOK JE; MAILLIARD JA; GERSTNER JB; PAZDUR R
      CONTROLLED CLINICAL-TRIAL OF INTERFERON-GAMMA AS POSTOPERATIVE SURGICAL ADJUVANT THERAPY FOR COLON-CANCER

      Journal of clinical oncology
    38. WITZIG TE; LETENDRE L; GERSTNER J; SCHROEDER G; MAILLIARD JA; COLONOTERO G; MARSCHKE RF; WINDSCHITL HE
      EVALUATION OF A SOMATOSTATIN ANALOG IN THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP TRIAL

      Journal of clinical oncology
    39. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA; TANGEN CM; UNGERLEIDER JS; EMERSON WA; TORMEY DC; GLICK JH; VEEDER MH; MAILLIARD JA
      INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER

      Journal of clinical oncology
    40. GOLDBERG RM; LOPRINZI CL; MAILLIARD JA; OFALLON JR; KROOK JE; GHOSH C; HESTORFF RD; CHONG SF; REUTER NF; SHANAHAN TG
      PENTOXIFYLLINE FOR TREATMENT OF CANCER ANOREXIA AND CACHEXIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Journal of clinical oncology
    41. HAYES DF; VANZYL JA; HACKING A; GOEDHALS L; BEZWODA WR; MAILLIARD JA; JONES SE; VOGEL CL; BERRIS RF; SHEMANO I; SCHOENFELDER J
      RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER

      Journal of clinical oncology
    42. SHAW EG; DEMING RL; CREAGAN ET; NAIR S; SU JQ; LEVITT R; STEEN PD; WIESENFELD M; MAILLIARD JA
      PILOT-STUDY OF HUMAN RECOMBINANT INTERFERON-GAMMA AND ACCELERATED HYPERFRACTIONATED THORACIC RADIATION-THERAPY IN PATIENTS WITH UNRESECTABLE STAGE IIIA B NONSMALL CELL LUNG-CANCER/

      International journal of radiation oncology, biology, physics
    43. INGLE JN; KROOK JE; MAILLIARD JA; HARTMANN LC; WIEAND HS
      EVALUATION OF IFOSFAMIDE PLUS MESNA AS FIRST-LINE CHEMOTHERAPY IN WOMEN WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    44. LONG HJ; CROSS WG; WIEAND HS; WEBB MJ; MAILLIARD JA; KUGLER JW; TSCHETTER LK; KARDINAL CG; EBBERT LP; RAYSON S
      PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA

      Gynecologic oncology
    45. BUCKNER JC; BROWN LD; KUGLER JW; CASCINO TL; KROOK JE; MAILLIARD JA; KARDINAL CG; TSCHETTER LK; OFALLON JR; SCHEITHAUER BW
      PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA

      Journal of neurosurgery
    46. GOLDBERG RM; MOERTEL CG; WIEAND HS; KROOK JE; SCHUTT AJ; VEEDER MH; MAILLIARD JA; DALTON RJ
      A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA

      Cancer
    47. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA; TANGEN CM; UNGERLEIDER JS; EMERSON WA; TORMEY DC; GLICK JH; VEEDER MH; MAILLIARD JA; GRAFF J
      FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT

      Annals of internal medicine
    48. LOPRINZI CL; GOLDBERG RM; SU JQ; MAILLIARD JA; KUROSS SA; MAKSYMIUK AW; KUGLER JW; JETT JR; GHOSH C; PFEIFLE DM; WENDER DB; BURCH PA
      PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    49. LOPRINZI CL; LAURIE JA; WIEAND HS; KROOK JE; NOVOTNY PJ; KUGLER JW; BARTEL J; LAW M; BATEMAN M; KLATT NE; DOSE AM; ETZELL PS; NELIMARK RA; MAILLIARD JA; MOERTEL CG
      PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES

      Journal of clinical oncology
    50. CULLINAN SA; MOERTEL CG; WIEAND HS; OCONNELL MJ; POON MA; KROOK JE; MAILLIARD JA; TSCHETTER LK
      CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER

      Journal of clinical oncology
    51. JETT JR; MAKSYMIUK AW; SU JQ; MAILLIARD JA; KROOK JE; TSCHETTER LK; KARDINAL CG; TWITO DI; LEVITT R; GERSTNER JB
      PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    52. BUROKER TR; OCONNELL MJ; WIEAND HS; KROOK JE; GERSTNER JB; MAILLIARD JA; SCHAEFER PL; LEVITT R; KARDINAL CG; GESME DH
      RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    53. MOERTEL CG; GUNDERSON LL; MAILLIARD JA; MCKENNA PJ; MARTENSON JA; BURCH PA; CHA SS
      EARLY EVALUATION OF COMBINED FLUOROURACIL AND LEUCOVORIN AS A RADIATION ENHANCER FOR LOCALLY UNRESECTABLE, RESIDUAL, OR RECURRENT GASTROINTESTINAL CARCINOMA

      Journal of clinical oncology
    54. MAKSYMIUK AW; JETT JR; EARLE JD; SU JQ; DIEGERT FA; MAILLIARD JA; KARDINAL CG; KROOK JE; VEEDER MH; WIESENFELD M; TSCHETTER LK; LEVITT R
      SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL

      Journal of clinical oncology
    55. GOLDBERG RM; LOPRINZI CL; OFALLON JR; VEEDER MH; MISER AW; MAILLIARD JA; MICHALAK JC; DOSE AM; ROWLAND KM; BURNHAM NL
      TRANSDERMAL CLONIDINE FOR AMELIORATING TAMOXIFEN-INDUCED HOT FLASHES

      Journal of clinical oncology
    56. INGLE JN; KUROSS SA; MAILLIARD JA; LOPRINZI CL; JUNG SH; NELIMARK RA; KROOK JE; LONG HJ
      EVALUATION OF PIROXANTRONE IN WOMEN WITH METASTATIC BREAST-CANCER ANDFAILURE ON NONANTHRACYCLINE CHEMOTHERAPY

      Cancer
    57. INGLE JN; FOLEY LF; MAILLIARD JA; KROOK JE; HARTMANN LC; JUNG SH; VEEDER MH; GESME DH; HATFIELD AK; GOLDBERG RM
      RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL WITH OR WITHOUT ESTROGENIC RECRUITMENT IN WOMEN WITH METASTATIC BREAST-CANCER

      Cancer
    58. WIESENFELD A; JETT JR; SU JQ; BRAICH TA; KARDINAL CG; MAILLIARD JA; VEEDER MH; MORTON RF; MICHALAK JC
      PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER

      Cancer
    59. WITZIG TE; GERSTNER J; MAILLIARD JA; SCHROEDER G
      EVALUATION OF A SOMATOSTATIN ANALOG (SMS-201-995, SANDOSTATIN(R)) IN THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP (NCCTG) TRIAL

      Blood
    60. SCOTT WJ; SCHWABE JL; GUPTA NC; DEWAN NA; REEB SD; SUGIMOTO JT; FRANK AR; GOBAR LS; MAILLIARD JA; MOULI B; SUNDERLAND JJ; TERRY JD; WALLACE F
      POSITRON EMISSION TOMOGRAPHY OF LUNG-TUMORS AND MEDIASTINAL LYMPH-NODES USING [F-18] FLUORODEOXYGLUCOSE

      The Annals of thoracic surgery
    61. BRINDLE JS; SHAW EG; SU JQ; MAILLIARD JA; FRANK AR; LAURIE JA; MCLEAN M; TACKETT DM; OWENS DT
      PILOT-STUDY OF ACCELERATED HYPERFRACTIONATED THORACIC RADIATION-THERAPY IN PATIENTS WITH UNRESECTABLE STAGE-III NONSMALL CELL LUNG-CARCINOMA

      Cancer
    62. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
      A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 22:48:23